Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR), which binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) at approximately 9-fold lower concentrations than wild-type. #Osicent80mg #Osimertinib #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/osicent-80-mg-osimertinib

Avalet 20 mg is an orally bioavailable, small-molecule TPO receptor agonist that stimulates the proliferation and differentiation of megakaryocytes from bone marrow progenitor cells, resulting in an increased production of platelets. #Avalet20mg #Avatrombopag #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/avalet-20-mg-avatrombopag

The American Academy of Dermatology Association says that researchers have looked at JAK inhibitors like tofacitinib and ruxolitinib as possible treatments for severe alopecia areata. #Barigen4mg #Baricitinib #Alopecia #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/baricitinib-4mg-barigen

Osimert is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test. #Osimert80mg #Osimertinib #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/osimert-80mg-osimertinib

Olanib is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. #Olanib150mg #Olaparib #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/olanib-olaparib-150mg

Tofacitinib is a partial and reversible janus kinase (JAK) inihibitor that will prevent the body from responding to cytokine signals. By inhibiting JAKs, tofacitinib prevents the phosphorylation and activation of STATs. #Alopecia #Tofacitinib5mg #Tofacent #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/tofacent-5mg-tofacitinib